Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults

NCT03293732 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Flu, Human

Interventions

BIOLOGICAL: DCB07010
BIOLOGICAL: HA antigens

Sponsor

Advagene Biopharma Co. Ltd.

Collaborators

[object Object]